Dr. Shuo Xiao is a tenured Associate Professor from the Department of Pharmacology and Toxicology at Rutgers University School of Pharmacy. He earned his MBBS in Preventive Medicine and MS in Toxicology from Peking University, followed by a PhD in Female Reproductive Biology and Toxicology from the University of Georgia. He completed his Postdoctoral training at Northwestern University School of Medicine. Dr. Xiao’s current research is dedicated to advancing women’s reproductive health, including (1) ovarian impacts of environmental contaminants and clinical drugs; (2) non-hormonal female contraception and fertoprotectant drug development, and (3) engineering female reproduction-on-chip. These projects are funded by NIH, DOD, NSF, and Bill & Melinda Gates Foundation. Dr. Xiao has published > 70 peer-reviewed papers in high impact journals, including PNAS, Nature Communications, Environmental Health Perspectives, Biology of Reproduction, and Toxicological Sciences. Dr. Xiao now serves as the President of American Association of Chinese in Toxicology (AACT), Secretary/Treasurer of SOT Reproductive and Developmental Specialty Section (RDTSS), and Chair of Basic Science Committee of Oncofertility Consortium. Dr. Xiao received several major awards to recognize his research in women’s reproductive health, such as the SOT Achievement Award, ASPET Toxicology Division Early Career Award, Society for the Study of Reproduction (SSR) New Investigator Award, the SOT/AACT JOINN Biomere Outstanding Young Toxicologist Award, and the SOT/RDTSS New-Career Scientist Award.

Curtis Grace, PhD is a Principal Scientist in Developmental and Reproductive Toxicology (DART), Nonclinical Drug Safety at Merck in West Point, PA. Dr. Grace works as a Study Director and Monitor  supporting multiple preclinical programs and modalities and has expertise in neurobehavioral toxicology assessments. Previously, he worked as a Study Director in the DART group at Covance Laboratories, Inc. Dr. Grace received his Ph.D. in Molecular and Developmental Biology from Cincinnati Children’s Hospital Research Foundation in 2010, where he focused on long-term neurobehavioral effects of developmental exposure to drugs of abuse. He was a postdoctoral fellow at the US EPA Toxicity Assessment Division from 2010-2012. Dr. Grace has over 20 publications in peer-reviewed scientific journals and is an active member the Society for Birth Defects Research and Prevention (BDRP) and MARTA. He has previously served on the BDRP Membership Committee and as MARTA councilor, and currently serves on the BDRP Student Affairs Committee and is involved in the Health & Environmental Sciences Institute (HESI) DART preweaning developmental endpoints and dystocia working groups. 

Bio Coming Soon

Johnathan Furr is currently the Director of Developmental and Reproductive Toxicology at Inotiv. Prior to joining Inotiv as a Senior Toxicologist (DART), he was Senior Scientist and Study Director at Southern Research for 5 years, and a Biologist at the US Environmental Protection Agency for 17 years, where his primary area of focus was male reproductive endocrinology. Johnathan is a Diplomate of the American Board of Toxicology and has co-authored over 50 peer-reviewed publications and abstract presentations in the field of Developmental and Reproductive Toxicology.

Bio Coming Soon.

Dr. Dilshan Harischandra is the Senior Manager DART at Labcorp in Greenfield, Indiana. In this role, he serves as a DART Study Director and leads a team of Study Directors and Study Coordinators. In addition to his managerial responsibilities, Dr. Harischandra also serves as the neurobehavioral subject matter expert for the DART business unit, where he leverages his neurotoxicology expertise to develop, optimize, and qualify neurobehavioral testing methods in both rodent and non-rodent species. Dr. Harischandra earned his PhD in Toxicology and BS in Genetics from Iowa State University, and an MBA in Project Management from the University of Southern Indiana. He completed his postdoctoral training at the University of Pennsylvania, specializing in translational neuroscience with a focus on gene therapy-based strategies for treating complex neurodegenerative diseases. He has authored over 30 peer-reviewed journal articles, three book chapters, and numerous abstracts presented at national and international conferences. He also contributes to the scientific community as a Topic Editor, Guest Editor, and ad hoc reviewer for several journals in the fields of neuroscience and toxicology. He has been a member of the SOT since 2010 and served as Councilor for the Metals Specialty Section from 2020 to 2022.

Bio Coming Soon.

Jessica Miller, PhD is a Developmental and Reproductive Toxicologist and Study Director at Inotiv, Inc. She specializes in rodent and rabbit developmental and reproductive toxicology including fertility (male and female), prenatal and postnatal development, juvenile, and multigenerational studies. Prior to her current role at Inotiv, Dr. Miller received her doctorate degree in Biomedical and Molecular sciences from Queen’s University in Kingston, Ontario, Canada where her research focused on reproductive immunology and infertility. She is currently an active member of the American College of Toxicology (ACT), Society of Toxicology (SOT), and Society for Birth Defects Research and Prevention (formerly the Teratology Society) and has published 24 peer-reviewed publications/abstracts in scientific journals. Most recently, she published a review in Trends and Molecular Medicine discussing emerging research avenues in the immunology of the female reproductive tract.